FR2235M - Médicament a base d'une combinaison de thioridazine et d'éther benzhydrylique du n-éthyl-nortropane. - Google Patents

Médicament a base d'une combinaison de thioridazine et d'éther benzhydrylique du n-éthyl-nortropane.

Info

Publication number
FR2235M
FR2235M FR902198A FR902198A FR2235M FR 2235 M FR2235 M FR 2235M FR 902198 A FR902198 A FR 902198A FR 902198 A FR902198 A FR 902198A FR 2235 M FR2235 M FR 2235M
Authority
FR
France
Prior art keywords
nortropane
thioridazine
ethyl
combination
product based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR902198A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to FR902198A priority Critical patent/FR2235M/fr
Application granted granted Critical
Publication of FR2235M publication Critical patent/FR2235M/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR902198A 1962-06-27 1962-06-27 Médicament a base d'une combinaison de thioridazine et d'éther benzhydrylique du n-éthyl-nortropane. Expired FR2235M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR902198A FR2235M (fr) 1962-06-27 1962-06-27 Médicament a base d'une combinaison de thioridazine et d'éther benzhydrylique du n-éthyl-nortropane.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR902198A FR2235M (fr) 1962-06-27 1962-06-27 Médicament a base d'une combinaison de thioridazine et d'éther benzhydrylique du n-éthyl-nortropane.

Publications (1)

Publication Number Publication Date
FR2235M true FR2235M (fr) 1963-12-30

Family

ID=87554139

Family Applications (1)

Application Number Title Priority Date Filing Date
FR902198A Expired FR2235M (fr) 1962-06-27 1962-06-27 Médicament a base d'une combinaison de thioridazine et d'éther benzhydrylique du n-éthyl-nortropane.

Country Status (1)

Country Link
FR (1) FR2235M (fr)

Similar Documents

Publication Publication Date Title
FR3806M (fr) Médicament a base d'un dérivé de la quinazolone-(4).
FR1367257A (fr) Agents d'unisson
FR2094M (fr) Médicament a base d'un nouvel hendécapeptide.
FR3405M (fr) Médicament a base d'une sulfométhyl-polymyxine.
FR3348M (fr) Médicament a base d'un nouveau dérivé de la 5.6-dihydromorphanthridine.
FR3148M (fr) Médicament a base d'un nouveau dérivé de la 5.6-dihydromorphanthridine.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR2235M (fr) Médicament a base d'une combinaison de thioridazine et d'éther benzhydrylique du n-éthyl-nortropane.
FR3809M (fr) Préparations pharmaceutiques a base d'éthers du glycérol.
FR2869M (fr) Médicament a base d'un dérivé de la cymarine.
FR3078M (fr) Médicament a base d'un nouveau polypeptide.
FR1732M (fr) Médicament a base d'amines secondaires tricycliques.
FR3724M (fr) Médicament a base d'anisoyl-3 hydroxy-4 p. méthoxy-phényl-6α-pyrone.
FR3351M (fr) Médicament a base d'un nouveau dérivé de la 1.2-diphényl-3.5-dioxo-pyrazolidine.
FR3323M (fr) Médicament a base de dérivé de l'aza-thiaxanthene.
FR2091M (fr) Médicament a base d'un dérivé du cyclohexene.
FR3301M (fr) Médicament a base d'un nouveau polypeptide.
FR2904M (fr) Médicament a base d'un nouveau polypeptide.
FR3223M (fr) Médicament a base d'un dérivé du dihydro-anthracene.
FR2034M (fr) Médicament a base d'une combinaison d'ocytocine et d'ergométrine ou de méthyl-ergométrine.
FR2907M (fr) Médicament a base de mélanges d'oligopeptides.
FR3565M (fr) Médicament a base d'un nonapeptide-amide cyclique.
FR2863M (fr) Nouveaux esters d'oestradiol.
FR2423M (fr) Médicament a base d'hydrazones du 5-nitro-furfural.
FR2877M (fr) Médicament a base d'amides.